691 - 700 of 8571 Results
Title
Year
-
RESTRICTEDTitle: Inflammatory profile discriminates clinical subtypes in LRRK2‐associated Parkinson's diseaseJournal Name: European Journal of NeurologyPublisher: WileyVol: 24Issue #: 2Start Page: 427End Page: 427Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/ene.13223Citation Count: 54
-
OPENTitle: Cathepsin B p.Gly284Val Variant in Parkinson’s Disease PathogenesisJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 23Issue #: 13Start Page: 7086End Page: 7086Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms23137086Best OA location URL: https://www.mdpi.com/1422-0067/23/13/7086/pdf?version=1656497147Citation Count: 15
- Exosome/microvesicle content is altered in leucine‐rich repeat kinase 2 mutant induced pluripotent stem cell‐derived neural cells2019RESTRICTEDTitle: Exosome/microvesicle content is altered in leucine‐rich repeat kinase 2 mutant induced pluripotent stem cell‐derived neural cellsJournal Name: Journal of Comparative NeurologyPublisher: WileyVol: 528Issue #: 7Start Page: 1203End Page: 1215Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/cne.24819Citation Count: 14
- Reply to: “Could Blood Hexosylsphingosine Be a Marker for Parkinson's Disease Linked with GBA1 Mutations”?2022RESTRICTEDTitle: Reply to: “Could Blood Hexosylsphingosine Be a Marker for Parkinson's Disease Linked with GBA1 Mutations”?Journal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 8Start Page: 1782End Page: 1782Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29136Citation Count: 0
-
OPENTitle: echolocatoR: an automated end-to-end statistical and functional genomic fine-mapping pipelineJournal Name: BioinformaticsPublisher: Oxford University Press (OUP)Vol: 38Issue #: 2Start Page: 536End Page: 539Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/bioinformatics/btab658Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/10060715Citation Count: 27
- The KV7.2/3 preferring channel opener ICA 27243 attenuates L-DOPA-induced dyskinesia in hemiparkinsonian rats2013RESTRICTEDTitle: The KV7.2/3 preferring channel opener ICA 27243 attenuates L-DOPA-induced dyskinesia in hemiparkinsonian ratsJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 545Issue #:Start Page: 59End Page: 63Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2013.04.017Citation Count: 7
-
RESTRICTED
- Characterization of extracellular vesicles and synthetic nanoparticles with four orthogonal single‐particle analysis platforms2021OPENTitle: Characterization of extracellular vesicles and synthetic nanoparticles with four orthogonal single‐particle analysis platformsJournal Name: Journal of Extracellular VesiclesPublisher: WileyVol: 10Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/jev2.12079Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jev2.12079Citation Count: 149
- Progressive loss of raphe nuclei serotonin transporter in early Parkinson's disease: A longitudinal 123I-FP-CIT SPECT study2019RESTRICTEDTitle: Progressive loss of raphe nuclei serotonin transporter in early Parkinson's disease: A longitudinal 123I-FP-CIT SPECT studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 77Issue #:Start Page: 170End Page: 175Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.03.025Citation Count: 38
- Neuroinflammation and L-dopa-induced abnormal involuntary movements in 6-hydroxydopamine-lesioned rat model of Parkinson's disease are counteracted by combined administration of a 5-HT1A/1B receptor agonist and A2A receptor antagonist2021RESTRICTEDTitle: Neuroinflammation and L-dopa-induced abnormal involuntary movements in 6-hydroxydopamine-lesioned rat model of Parkinson's disease are counteracted by combined administration of a 5-HT1A/1B receptor agonist and A2A receptor antagonistJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 196Issue #:Start Page: 108693End Page: 108693Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2021.108693Best OA location URL: https://hdl.handle.net/11584/325357Citation Count: 17